Press Releases

Press Releases

Provectus Biopharmaceuticals, Inc., a clinical-stage oncology and dermatology biopharmaceutical company, today announced that it had extended for an additional 60 days its Memorandum of Understanding with with Sinopharm-China State Institute of Pharmaceutical Industry ("Sinopharm-CSIPI"), the leader among all pharmaceutical research institutes in China, and Sinopharm A-THINK Pharmaceutical Co., Ltd. ("Sinopharm…

Press Releases

ExeGi Pharma, a company focused on developing and commercializing live biotherapeutics and probiotic treatments, announced today that it has signed an agreement with Professor Claudio De Simone, MD, PhD, to produce a generic formulation of the probiotic marketed under the name "VSL#3®." ExeGi Pharma will commercialize Visbiome™ and Visbiome™ Extra…

Press Releases

Regeneron Pharmaceuticals, Inc. and Sanofi today shared positive results from an interim analysis of a pivotal Phase 2b study of dupilumab in adult patients with moderate-to-severe asthma, who are uncontrolled despite treatment with inhaled corticosteroids and long-acting beta agonists (ICS/LABA). As previously reported, the study met its primary endpoint of…

Press Releases

MCI Group is proud to announce the 2nd Annual MENA Pharmaceutical Cold Chain Forum, which will be held in Dubai on 2nd and 3rd June 2015. The forum is supported by Dubai Customs, Saudi Pharmaceutical Society and Supply Chain & Logistics Group According to a report by IMARC, the total…

Press Releases

Astellas Pharma Inc and Medivation, Inc today announced data from the Phase 2 STRIVE trial comparing enzalutamide and bicalutamide in non-metastatic (M0) and metastatic (M1) prostate cancer patients whose disease progressed despite treatment with a luteinizing hormone-releasing hormone (LHRH) analogue therapy or following surgical castration. The data were presented during…

Press Releases

Jazz Pharmaceuticals plc today announced that the company will be webcasting its corporate presentations at two upcoming investor conferences. •    UBS Global Healthcare Conference in New York, NY on Wednesday, May 20, 2015 at 8:00 a.m. EDT / 1:00 p.m. IST.  Bruce Cozadd, chairman and chief executive officer, will provide…

Press Releases

Iroko Pharmaceuticals Inc., a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that ZORVOLEX® (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), is now available in 18 mg and 35 mg dosage strengths by prescription in Lebanon. ZORVOLEX was approved by the Republic of Lebanon Ministry…

Press Releases

Cortendo AB, a biopharmaceutical company focused on rare endocrine disorders and other rare diseases, and Antisense Therapeutics Limited [ticker: ANP on ASX] today announced that the companies have entered into an exclusive license agreement that provides Cortendo with development and commercialization rights to Antisense Therapeutics’ ATL1103 for endocrinology applications. Under…

Press Releases

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today announced it has entered into Contract No. W81XWH-15-C-0046 worth up to $17.0 million, supported by the United States Army Medical Research and Materiel Command (USAMRMC) within the…

Press Releases

M Pharmaceutical Inc. a Canadian company committed to developing and commercializing innovative biomedical technologies that improve the health and quality of life for people affected by obesity and diabetes, announced today that it has achieved an important milestone in the development of the e-Mosquito, a wearable blood glucose monitoring system…